| Coronavirus goes viral: quantifying the COVID-19 misinformation epidemic on Twitter R Kouzy, J Abi Jaoude, A Kraitem, MB El Alam, B Karam, E Adib, J Zarka, ... Cureus 12 (3), 2020 | 1093 | 2020 |
| Distribution of KRASG12C Somatic Mutations across Race, Sex, and Cancer Type AH Nassar, E Adib, DJ Kwiatkowski New England Journal of Medicine 384 (2), 185-187, 2021 | 184 | 2021 |
| Association of machine learning–based assessment of tumor-infiltrating lymphocytes on standard histologic images with outcomes of immunotherapy in patients with NSCLC M Rakaee, E Adib, B Ricciuti, LM Sholl, W Shi, JV Alessi, A Cortellini, ... JAMA oncology 9 (1), 51-60, 2023 | 93 | 2023 |
| CDKN2A Alterations and Response to Immunotherapy in Solid Tumors E Adib, AH Nassar, EW Akl, S Abou Alaiwi, PV Nuzzo, TH Mouhieddine, ... Clinical Cancer Research 27 (14), 4025-4035, 2021 | 91 | 2021 |
| Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors AH Nassar, E Adib, S Abou Alaiwi, T El Zarif, S Groha, EW Akl, PV Nuzzo, ... Cancer Cell 40 (10), 1161-1172. e5, 2022 | 83 | 2022 |
| Germline variants associated with toxicity to immune checkpoint blockade S Groha, SA Alaiwi, W Xu, V Naranbhai, AH Nassar, Z Bakouny, T El Zarif, ... Nature medicine 28 (12), 2584-2591, 2022 | 70 | 2022 |
| Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology E Adib, AH Nassar, S Abou Alaiwi, S Groha, EW Akl, LM Sholl, ... Genome Medicine 14 (1), 39, 2022 | 56 | 2022 |
| Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer S Zhu, AH Ma, Z Zhu, E Adib, T Rao, N Li, K Ni, VCSR Chittepu, ... Journal for immunotherapy of cancer 9 (11), e002917, 2021 | 42 | 2021 |
| & Baddour, K.(2020). Coronavirus goes viral: quantifying the COVID-19 misinformation epidemic on Twitter R Kouzy, J Abi Jaoude, A Kraitem, MB El Alam, B Karam, E Adib Cureus 12 (3), e7255, 0 | 36 | |
| Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations E Adib, K Klonowska, K Giannikou, KT Do, S Pruitt-Thompson, K Bhushan, ... Clinical Cancer Research 27 (14), 3845-3853, 2021 | 35 | 2021 |
| Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the cancer therapy using checkpoint inhibitors in people … T El Zarif, AH Nassar, E Adib, BG Fitzgerald, J Huang, TH Mouhieddine, ... Journal of Clinical Oncology 41 (21), 3712-3723, 2023 | 34 | 2023 |
| CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer E Adib, T El Zarif, AH Nassar, EW Akl, S Abou Alaiwi, TH Mouhieddine, ... British journal of cancer 126 (5), 797-803, 2022 | 30 | 2022 |
| The prostate cancer androgen receptor cistrome in African American men associates with upregulation of lipid metabolism and immune response JE Berchuck, E Adib, S Abou Alaiwi, AK Dash, JN Shin, D Lowder, ... Cancer research 82 (16), 2848-2859, 2022 | 27 | 2022 |
| Consolidation osimertinib versus durvalumab versus observation after concurrent chemoradiation in unresectable EGFR-Mutant NSCLC: a multicenter retrospective cohort study AH Nassar, SY Kim, JV Aredo, J Feng, F Shepherd, C Xu, D Kaldas, ... Journal of Thoracic Oncology 19 (6), 928-940, 2024 | 24 | 2024 |
| Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review … Y Fujiwara, N Horita, E Adib, S Zhou, AH Nassar, ZULA Asad, A Cortellini, ... The Lancet Oncology 25 (1), 62-75, 2024 | 24 | 2024 |
| Epigenomic charting and functional annotation of risk loci in renal cell carcinoma AH Nassar, S Abou Alaiwi, SC Baca, E Adib, RI Corona, JH Seo, ... Nature communications 14 (1), 346, 2023 | 20 | 2023 |
| Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance D Gjuka, E Adib, K Garrison, J Chen, Y Zhang, W Li, D Boutz, C Lamb, ... Cancer Cell 41 (10), 1774-1787. e9, 2023 | 19* | 2023 |
| Trans-ethnic variation in germline variants of patients with renal cell carcinoma S Abou Alaiwi, AH Nassar, E Adib, SM Groha, EW Akl, BA McGregor, ... Cell reports 34 (13), 2021 | 19 | 2021 |
| Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors PV Nuzzo, E Adib, N Weise, C Curran, T Stewart, D Freeman, AH Nassar, ... Clinical genitourinary cancer 20 (4), 301-306, 2022 | 18 | 2022 |
| Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia S Tahri, TH Mouhieddine, R Redd, L Lampe, KI Nilsson, H El-Khoury, ... Blood Advances 6 (7), 2230-2235, 2022 | 18 | 2022 |